Optimi Health Corp. (FRA:8BN)

Market Cap	20.40M +46.4%
Revenue (ttm)	120.26K -62.6%
Net Income	-2.49M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,750
Average Volume	3,050
Open	0.2060
Previous Close	0.2300
Day's Range	0.2060 - 0.2060
52-Week Range	0.0775 - 0.2600
Beta	n/a
RSI	51.47
Earnings Date	Jan 29, 2026

About Optimi Health

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was fo...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8BN

Financial Performance

In fiscal year 2025, Optimi Health's revenue was 426,301, an increase of 9.35% compared to the previous year's 389,850. Losses were -3.71 million, -38.50% less than in 2024.

Financial numbers in CAD